Concepts (67)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Astrocytes | 4 | 2009 | 244 | 0.600 |
Why?
|
| Cannabinoids | 2 | 2007 | 73 | 0.350 |
Why?
|
| Cerebral Cortex | 2 | 2009 | 306 | 0.310 |
Why?
|
| Epoxide Hydrolases | 1 | 2009 | 8 | 0.300 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 77 | 0.290 |
Why?
|
| Excitatory Amino Acids | 1 | 2007 | 7 | 0.260 |
Why?
|
| Sodium | 1 | 2007 | 102 | 0.250 |
Why?
|
| Biological Transport | 1 | 2007 | 204 | 0.250 |
Why?
|
| Arachidonic Acids | 2 | 2007 | 25 | 0.190 |
Why?
|
| Piperidines | 2 | 2007 | 83 | 0.180 |
Why?
|
| Pyrazoles | 2 | 2007 | 103 | 0.180 |
Why?
|
| Cells, Cultured | 5 | 2009 | 1621 | 0.180 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2020 | 11 | 0.170 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 46 | 0.160 |
Why?
|
| Histone Deacetylases | 1 | 2020 | 61 | 0.160 |
Why?
|
| Adrenergic Agonists | 1 | 1999 | 2 | 0.160 |
Why?
|
| Epinephrine | 1 | 1999 | 36 | 0.160 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 1999 | 13 | 0.160 |
Why?
|
| Norepinephrine | 1 | 1999 | 97 | 0.150 |
Why?
|
| Glioblastoma | 1 | 2020 | 74 | 0.150 |
Why?
|
| Arachidonic Acid | 2 | 1996 | 35 | 0.150 |
Why?
|
| Cyclic AMP | 1 | 1999 | 127 | 0.150 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 140 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2009 | 1766 | 0.140 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2009 | 75 | 0.140 |
Why?
|
| Rats | 5 | 2009 | 3735 | 0.140 |
Why?
|
| Animals, Newborn | 2 | 2009 | 352 | 0.130 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 1995 | 5 | 0.120 |
Why?
|
| Phospholipids | 1 | 1995 | 70 | 0.110 |
Why?
|
| Protein Kinase C | 1 | 1995 | 124 | 0.110 |
Why?
|
| Morpholines | 2 | 2020 | 72 | 0.100 |
Why?
|
| Polyunsaturated Alkamides | 2 | 2007 | 15 | 0.100 |
Why?
|
| Endocannabinoids | 2 | 2007 | 41 | 0.090 |
Why?
|
| Neurons | 1 | 1999 | 1263 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2020 | 2157 | 0.090 |
Why?
|
| Animals | 6 | 2020 | 16992 | 0.080 |
Why?
|
| Neoplasms | 1 | 2020 | 1377 | 0.080 |
Why?
|
| Cyclohexanols | 1 | 2007 | 11 | 0.070 |
Why?
|
| Naphthalenes | 1 | 2007 | 38 | 0.060 |
Why?
|
| Benzoxazines | 1 | 2007 | 47 | 0.060 |
Why?
|
| Aspartic Acid | 1 | 2007 | 51 | 0.060 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2007 | 64 | 0.060 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2007 | 41 | 0.060 |
Why?
|
| Kinetics | 1 | 2007 | 695 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 934 | 0.050 |
Why?
|
| Proteins | 1 | 2007 | 382 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1124 | 0.050 |
Why?
|
| Time Factors | 1 | 2007 | 1857 | 0.050 |
Why?
|
| Superior Cervical Ganglion | 1 | 1999 | 4 | 0.040 |
Why?
|
| Receptors, Adrenergic | 1 | 1999 | 10 | 0.040 |
Why?
|
| Quinoxalines | 1 | 1999 | 16 | 0.040 |
Why?
|
| Isoproterenol | 1 | 1999 | 39 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2020 | 139 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 277 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 291 | 0.030 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1996 | 5 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 1996 | 12 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 1996 | 25 | 0.030 |
Why?
|
| Phospholipases | 1 | 1995 | 7 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1995 | 9 | 0.030 |
Why?
|
| Phosphatidylinositols | 1 | 1995 | 13 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1995 | 465 | 0.020 |
Why?
|
| Apoptosis | 1 | 2020 | 1568 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 1019 | 0.020 |
Why?
|
| Mice | 1 | 2020 | 6644 | 0.020 |
Why?
|
| Humans | 2 | 2020 | 43102 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 13872 | 0.010 |
Why?
|